Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
Year: 1999
Type: article
Study design: Clinical Trial
Authors: J SCHWARTZ, C CHAN, S MUKHOPADHYAY, K MCBRIDE, T JONES, S ADCOCK, C MORITZ, J HEDGES, K GRASING, D DOBRATZ
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1987407100